FDA flags psychiatric risks of asthma drugs

Friday, June 12, 2009 - 16:28 in Health & Medicine

WASHINGTON (AP) -- New labels on popular asthma drugs like Merck's Singulair must highlight language about suicidal behavior, depression and anxiety seen in a small number of patients, federal regulators said Friday....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net